FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar
- FDA: 5 events in the last 90 days
- Previous: earlier the same day · HHS is planning to create two new FDA deputy commissioner roles, including one for AI
What happened
The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
Summary assembled by rule from the sources below
Why it's spreading
Timeline
- First appeared on FDA Press ReleasesFDA Press Releases
- Discussion started on Hacker NewsHacker News